Telix and ITM merger creates radiopharmaceutical giant
Listed global biopharmaceutical company Telix Pharmaceuticals has announced a strategic merger with German radiopharmaceutical biotechnology company ITM Isotope Technologies Munich. The transaction signals a significant shift toward vertical integration in the radiopharmaceutical sector. The transaction, valued at US$1.65 billion upfront plus up to US$700 million in potential milestone payments, aims to secure Telix’s position as a global leader in precision…
Circle Health acquiring laboratory facilities from Unilabs Ltd in UK
PureHealth, the largest healthcare group in the Middle East, has confirmed that its subsidiary Circle Health Group has entered into an agreement to take over selected UK laboratory operations from Unilabs Limited. This establishes a new integrated diagnostics platform for Circle Health, the largest independent hospital operator in Britain, which was itself acquired by PureHealth for $1.2 billion in 2023.…
Spire agrees £1bn takeover
Prominent UK private hospital operator Spire Healthcare Group has reached an agreement on the terms of a recommended cash takeover by Tulip UK Bidco Limited. The transaction values Spire’s entire issued and to be issued ordinary share capital at approximately £1.03bn on a fully diluted basis, representing an enterprise value of roughly £2.31bn. Tulip UK Bidco is a newly formed…
Terveystalo acquiring Solo Health Group
Terveystalo, the largest private healthcare service provider in Finland, is to acquire the entire share capital of Solo Health Group. The transaction marks a significant consolidation in the Nordic healthcare services market. The transaction is part of Terveystalo’s strategy to deepen its partnership with Finland’s wellbeing services counties. By absorbing Solo Health, Terveystalo will significantly expand its nationwide professional network,…
Radiology Partners acquiring Everlight Radiology in AUD1bn deal
Radiology Partners, the leading American provider of technology and AI-enabled imaging services, is to acquire Everlight Radiology in an AUD1bn deal. Candesic provided AI vendor commercial due diligence to Everlight Radiology. Candesic’s work focused on commercial due diligence of Everlight’s AI capabilities. The transaction creates a dominant global force in the teleradiology sector by unifying the largest domestic platform in the…
Candesic advises Everlight Radiology on AUD1bn acquisition by Radiology Partners
Candesic has provided AI vendor commercial due diligence to Everlight Radiology in support of its AUD1bn acquisition by Radiology Partners, the leading provider of technology and AI-enabled radiology services in the US. The transaction will bring together Everlight’s international teleradiology network with Radiology Partners’ vRad platform, creating a leading global teleradiology business. The combination will connect the organisations’ technology, clinical…
Candesic advises ARCHIMED on investment in Renata Medical
Paediatric medical device company Renata Medical has just closed a $25m Series D financing round. The round was led by global private equity investment firm ARCHIMED Candesic is delighted to have supported ARCHIMED with commercial due diligence on the investment in Renata, a US-based technology company focused on developing cardiovascular devices specifically for children with congenital heart disease. The Candesic…
argenx to acquire Forte Biosciences for $2.2bn
Dutch-Belgian immunology group argenx SE has entered a definitive agreement to acquire US-based biopharma group Forte Biosciences in an all-cash transaction valued at approximately $2.2bn. This deal, the largest in the history of the Euronext-listed firm, marks a significant pivot as argenx seeks to diversify its portfolio beyond its flagship blockbuster treatment, Vyvgart. Under the terms of the agreement, argenx…
Healthcare Activos launches new hospital platform
Healthcare Activos launched its newest strategic vehicle, Healthcare Activos Hospitals, on Tuesday, July 22. Created in partnership with a group of long term institutional investors, the platform has an initial investment target of €800m. The platform has acquired three hospitals in Portugal from Praemia REIM and Icade for a total transaction value, including planned expansion capital, of up to €250…
Ardian takes majority control of Pflegia
Global private investment firm Ardian is acquiring a majority stake in Berlin-based digital healthcare recruitment platform Pflegia. Founded in 2019, Pflegia operates an AI powered reverse recruiting platform that connects healthcare professionals with care providers by matching candidate preferences with institutional needs. This transaction marks a significant move for Ardian Growth, the specialist team within the firm that focuses on…